Aerie Pharmaceuticals

Aerie Pharmaceuticals financials

Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

Aerie Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

$15.3

2022-11-22

Market Capitalization

$722.2 M

2022-11-22

Revenue

$194.1 M

FY, 2021

CreditSafe score

Score changed on Apr 02, 2023

Premium Content

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016	FY, 2017	FY, 2018	FY, 2019	FY, 2020	FY, 2021
Revenue						24.2M	69.9M	83.1M	194.1M
Cost of goods sold						641.0K	22.8M	25.3M	26.8M
Gross profit						23.5M	47.1M	57.8M
Gross profit margin, %						97.3%	67.4%	69.5%
General and administrative expense					73.6M	120.6M	138.4M	137.2M	137.8M
Operating expense total					145.7M	233.3M	234.6M	213.5M	213.6M
EBIT	(22.2M)	(50.0M)	(75.1M)	(96.9M)	(145.7M)	(209.7M)	(187.5M)	(155.7M)	(46.4M)
EBIT margin, %						-867.4%	-268.3%	-187.3%
Pre tax profit			(74.2M)	(98.9M)	(146.9M)	(232.6M)	(199.7M)	(177.9M)	(74.2M)
Income tax expense			139.0K	193.0K	(1.8M)	3.0K	(90.0K)	5.2M	593.0K
Net Income	(31.1M)	(48.1M)	(74.4M)	(99.1M)	(145.1M)	(232.6M)	(199.6M)	(183.1M)	(74.8M)